Common supplement reverses premature aging in landmark human trial

Why is Warner Bros. Discovery splitting in two? How will Amazon’s $20B Pennsylvania cloud investment affect AI? What caused Tesla’s stock downgrades after Musk-Trump feud? Why did OpenAI hit $10 billion in annual recurring revenue? How will Trump’s National Guard deployment impact LA protests? What are the effects of US-China trade talks in London? Why is Apple redesigning iOS with 'Liquid Glass' interface?

Common supplement reverses premature aging in landmark human trial

sciencedaily.com/releases/2025/06/250609020625.htm

Common supplement reverses premature aging in landmark human trial
Researchers reported that nicotinamide riboside, vitamin B3 derivative, enhances cardiovascular, skin, and kidney health in patients with progeroid disease
- Date:
- June 9, 2025
- Source:
- Chiba University
- Summary:
-…

This story appeared on sciencedaily.com, 2025-06-09 13:15:40.382000.